June 25, 2024 02:54 PM EDT

Amgen calls Colorado's price controls on Enbrel 'unconstitutional'

Zachary Brennan

Senior Editor

Amgen on Monday called on a Colorado federal court to overturn the state drug affordability board’s decision to cap the price of Amgen’s blockbuster biologic …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Amgen calls Colorado's price controls on Enbrel 'unconstitutional'

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

The Endpoints 11 winners: Big bets on AI, new frontiers in editing, a neuro renaissance and Chinese chemistry

Exclusive: J&J folds cardiovascular and metabolic drug unit

FDA approves Bristol Myers and Karuna's schizophrenia drug, in milestone for psychiatry

FDA approves Dupixent in COPD, opening ‘next chapter’ for Sanofi and Regeneron’s bestseller

Novo Nordisk to decrease some insulin pen manufacturing, transition supply

PDCs vs. ADCs: A New Frontier in Targeted Cancer Therapies and the Potential for Development Partnerships

Am­gen calls Col­orado's price con­trols on En­brel 'un­con­sti­tu­tion­al'

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Amgen calls Colorado's price controls on Enbrel 'unconstitutional'